Innoviva (INVA) Cost of Revenue (2011 - 2026)
Innoviva (INVA) posted Cost of Revenue of $22.35 million for Q2 2026, up 111.0% from $10.59 million a year earlier and up 43.2% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Cost of Revenue (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Innoviva was $95.91 million, up 162.1% year-over-year; for FY2025, it came in at $77.38 million, up 111.4% from FY2024.
- Annual Cost of Revenue shows a three-year compound annual growth rate of 77.7% (FY2022 to FY2025).
- In prior years, Innoviva's Cost of Revenue was $36.6 million in FY2024 (-10.8%), $41.04 million in FY2023 (+197.5%) and $13.79 million in FY2022.
- Quarterly Cost of Revenue has run from a low of $3.68 million in Q4 2022 to a high of $32.31 million in Q4 2025 over five years.
- On a year-over-year basis, Cost of Revenue has increased in each of the last five quarters, with growth averaging 116.8% over the last six quarters.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was Q4 2025, with growth of 350.9%; the weakest was Q1 2025, with a decline of 19.4%.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $15.61 million (Q1 2026), $32.31 million (Q4 2025) and $25.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | 22.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.35 Mn |
| Mar 31, 2026 | 15.61 Mn |
| Dec 31, 2025 | 32.31 Mn |
| Sep 30, 2025 | 25.64 Mn |
| Jun 30, 2025 | 10.59 Mn |
| Mar 31, 2025 | 8.84 Mn |
| Dec 31, 2024 | 7.17 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 8.47 Mn |
| Mar 31, 2024 | 10.97 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 8.98 Mn |
| Mar 31, 2023 | 8.75 Mn |
| Sep 30, 2022 | 3.68 Mn |
| Mar 31, 2014 | 188,000.00 |
| Jun 30, 2011 | 1.18 Mn |
API Access
Innoviva Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();